- Home
- KIDS vs NPCE Comparison
KIDS vs NPCE Comparison
Compare KIDS & NPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KIDS | NPCE |
|---|---|---|
| Founded | 2007 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 469.9M | 485.6M |
| IPO Year | 2016 | 2021 |
Fundamental Metrics
Financial Performance| Metric | KIDS | NPCE |
|---|---|---|
| Price | $18.04 | $14.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 6 |
| Target Price | ★ $24.67 | $18.33 |
| AVG Volume (30 Days) | 109.2K | ★ 171.7K |
| Earning Date | 05-14-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.03 |
| EPS | N/A | ★ N/A |
| Revenue | $98,049,000.00 | ★ $99,986,000.00 |
| Revenue This Year | $14.07 | $25.95 |
| Revenue Next Year | $11.85 | $0.28 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 37.95 | 25.13 |
| 52 Week Low | $15.34 | $7.56 |
| 52 Week High | $26.40 | $18.97 |
Technical Indicators
Market Signals| Indicator | KIDS | NPCE |
|---|---|---|
| Relative Strength Index (RSI) | 54.20 | 42.40 |
| Support Level | $16.11 | $9.52 |
| Resistance Level | $19.15 | $16.96 |
| Average True Range (ATR) | 0.94 | 0.83 |
| MACD | 0.16 | -0.05 |
| Stochastic Oscillator | 52.91 | 50.16 |
Price Performance
Historical ComparisonAbout KIDS OrthoPediatrics Corp.
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.